Cargando…
SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849564/ https://www.ncbi.nlm.nih.gov/pubmed/32299904 http://dx.doi.org/10.3324/haematol.2020.249276 |
| _version_ | 1783645330648072192 |
|---|---|
| author | Gerlach, Magdalena M. Stelling-Germani, Anna Wu, Cheuk Ting Newrzela, Sebastian Döring, Claudia Vela, Visar Müller, Anne Hartmann, Sylvia Tzankov, Alexandar |
| author_facet | Gerlach, Magdalena M. Stelling-Germani, Anna Wu, Cheuk Ting Newrzela, Sebastian Döring, Claudia Vela, Visar Müller, Anne Hartmann, Sylvia Tzankov, Alexandar |
| author_sort | Gerlach, Magdalena M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7849564 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78495642021-02-03 SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy Gerlach, Magdalena M. Stelling-Germani, Anna Wu, Cheuk Ting Newrzela, Sebastian Döring, Claudia Vela, Visar Müller, Anne Hartmann, Sylvia Tzankov, Alexandar Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-04-16 /pmc/articles/PMC7849564/ /pubmed/32299904 http://dx.doi.org/10.3324/haematol.2020.249276 Text en Copyright© 2021 Ferrata Storti Foundation http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Gerlach, Magdalena M. Stelling-Germani, Anna Wu, Cheuk Ting Newrzela, Sebastian Döring, Claudia Vela, Visar Müller, Anne Hartmann, Sylvia Tzankov, Alexandar SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy |
| title | SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy |
| title_full | SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy |
| title_fullStr | SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy |
| title_full_unstemmed | SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy |
| title_short | SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy |
| title_sort | smad1 promoter hypermethylation and lack of smad1 expression in hodgkin lymphoma: a potential target for hypomethylating drug therapy |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849564/ https://www.ncbi.nlm.nih.gov/pubmed/32299904 http://dx.doi.org/10.3324/haematol.2020.249276 |
| work_keys_str_mv | AT gerlachmagdalenam smad1promoterhypermethylationandlackofsmad1expressioninhodgkinlymphomaapotentialtargetforhypomethylatingdrugtherapy AT stellinggermanianna smad1promoterhypermethylationandlackofsmad1expressioninhodgkinlymphomaapotentialtargetforhypomethylatingdrugtherapy AT wucheukting smad1promoterhypermethylationandlackofsmad1expressioninhodgkinlymphomaapotentialtargetforhypomethylatingdrugtherapy AT newrzelasebastian smad1promoterhypermethylationandlackofsmad1expressioninhodgkinlymphomaapotentialtargetforhypomethylatingdrugtherapy AT doringclaudia smad1promoterhypermethylationandlackofsmad1expressioninhodgkinlymphomaapotentialtargetforhypomethylatingdrugtherapy AT velavisar smad1promoterhypermethylationandlackofsmad1expressioninhodgkinlymphomaapotentialtargetforhypomethylatingdrugtherapy AT mulleranne smad1promoterhypermethylationandlackofsmad1expressioninhodgkinlymphomaapotentialtargetforhypomethylatingdrugtherapy AT hartmannsylvia smad1promoterhypermethylationandlackofsmad1expressioninhodgkinlymphomaapotentialtargetforhypomethylatingdrugtherapy AT tzankovalexandar smad1promoterhypermethylationandlackofsmad1expressioninhodgkinlymphomaapotentialtargetforhypomethylatingdrugtherapy |